Viatris Inc. (VTRS)

Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$19.63-1.26%As of 2026-11-22 · USD
Last session low $19.43Last session high $20.09
52-week low $10.3952-week high $21.20
Market cap
$22.50B
Sector
Healthcare
Dividend yield
2.44%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)52.7In the neutral range (30 to 70)
MACD (12, 26, 9)0.55Below its signal line (0.65); histogram -0.10
Bollinger %B (20, 2)47%Inside the bands (18.00 to 21.46)
SMA 2019.73Price is 0.5% below
SMA 5018.47Price is 6.3% above
SMA 20016.40Price is 19.7% above
ATR (20)2.75% of priceAverage true range per day
52-week position85%In the upper part of the 10.39 to 21.20 range

About Viatris Inc.

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.

Latest fiscal yearEnded 2025-12-31: revenue of $14.30B and an operating margin of 1.8%.

More in Drug Manufacturers - Specialty & Generic